Chewy, Bausch Health Companies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

BenzingaMar 26 07:07 ET

RegenXBio Positioned Favorably Amid Competitor Safety Concerns, Justifying Buy Rating

TipRanksMar 21 03:06 ET · Ratings

H.C. Wainwright Maintains Regenxbio(RGNX.US) With Buy Rating, Maintains Target Price $34

Moomoo NewsMar 21 02:31 ET · Ratings

Optimistic Buy Rating for RegenXBio Driven by Promising RGX-202 Developments in DMD Treatment

TipRanksMar 20 11:05 ET · Ratings

Analysts Are Neutral on These Healthcare Stocks: Medtronic (MDT), RegenXBio (RGNX)

TipRanksMar 20 09:10 ET · Ratings

Regenxbio's DMD Gene Therapy Drives 122.3% Biomarker Uptick in Three-year-old

Yahoo FinanceMar 20 07:53 ET